Metalloproteinase inhibitors: Biological actions and therapeutic opportunities

Journal of Cell Science

Volumn 115, Issue 19, 2002, Pages 3719-3727

  Baker, Andrew H ^a   Edwards, Dylan R ^a   Murphy, Gillian ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

MMP; RECK; Therapy; TIMP

Indexed keywords

ALPHA 2 MACROGLOBULIN; ANGIOSTATIN; ASTACIN; COLLAGENASE 3; CYCLIC AMP; CYSTEINE; CYTOKINE; DISINTEGRIN; ENDOSTATIN; GELATINASE B; GUANINE NUCLEOTIDE BINDING PROTEIN; MARIMASTAT; MATRIX METALLOPROTEINASE; METALLOPROTEINASE INHIBITOR; METZENCIN; NETRIN; PROCOLLAGEN C PROTEINASE; PROTEIN P53; RO 113 2908; SERINE PROTEINASE INHIBITOR; THROMBOSPONDIN 1; THROMBOSPONDIN 2; TISSUE FACTOR PATHWAY INHIBITOR; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2; TISSUE INHIBITOR OF METALLOPROTEINASE 3; TISSUE INHIBITOR OF METALLOPROTEINASE 4; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; UNINDEXED DRUG; ZINC ION;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTHRITIS; ARTICLE; CANCER; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; DEGENERATIVE DISEASE; EXTRACELLULAR SPACE; GENE THERAPY; HUMAN; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN MOTIF; PROTEIN TRANSPORT; REGULATORY MECHANISM;

ALPHA-MACROGLOBULINS; ANIMALS; CARDIOVASCULAR DISEASES; CELL MEMBRANE; EUKARYOTIC CELLS; HUMANS; MATRIX METALLOPROTEINASES; NEOPLASMS; PROTEIN STRUCTURE, TERTIARY; RECOMBINANT FUSION PROTEINS; TISSUE INHIBITOR OF METALLOPROTEINASES;

ANIMALIA;

EID: 0036800192     PISSN: 00219533     EISSN: None     Source Type: Journal    
DOI: 10.1242/jcs.00063     Document Type: Article

References (90)

1. Ahonen, M., Baker, A. H. and Kahari, V. M. (1998). Adenovirus-mediated gene delivery of tissue inhibitor of metalloproteinases-3 inhibits invasion and induces apoptosis in melanoma cells. Cancer Res. 58, 2310-2315.
2. Ahonen, M., Ala-Aho, R., Baker, A., George, S., Grenman, R., Saarialho-Kere, U. and Kahari, V.-M. (2002). Antitumour activity and bystander effect of adenovirally delivered tissue inhibitor of metalloproteinases-3. Mol. Ther. 5, 705-715.
3. Alexander, C. M., Hansell, E. J., Behrendtsen, O., Flannery, M. L., Kishnani, N. S., Hawkes, S. P. and Werb, Z. (1996). Expression and function of matrix metalloproteinases and their inhibitors at the maternal-embryonic boundary during mouse embryo implantation. Development 122, 1723-1736.
4. Amour, A., Slocombe, P. M., Webster, A., Butler, M., Knight, C. G., Smith, B. J., Stephens, P. E., Shelley, C., Hutton, M., Knauper, V. et al. (1998). TNF-alpha converting enzyme (TACE) is inhibited by TIMP-3. FEBS Lett. 435, 39-44.
5. Amour, A., Knight, C. G., Webster, A., Slocombe, P. M., Stephens, P. E., Knauper, V., Docherty, A. J. P. and Murphy, G. (2000). The in vitro activity of ADAM-10 is inhibited by TIMP-1 and TIMP-3. FEBS Lett. 473, 275-279.
6. Anand-Apte, B., Pepper, M. S., Voest, E., Montesano, R., Olsen, B., Murphy, G., Apte, S. S. and Zetter, B. (1997). Inhibition of angiogenesis by tissue inhibitor of metalloproteinase-3. Invest. Ophthalmol. Vis. Sci. 38, 817-823.
7. Armstrong, P. B. and Quigley, J. P. (1999). Alpha2-macroglobulin, an evolutionarily conserved arm of the innate immune system. Dev. Comp. Immunol 23, 375-390.
8. Baker, A. H., Zaltsman, A. B., George, S. J. and Newby, A. C. (1998). Divergent effects of tissue inhibitor of metalloproteinase-l,-2, or -3 overexpression on rat vascular smooth muscle cell invasion, proliferation, and death in vitro. TIMP-3 promotes apoptosis. J. Clin. Invest. 101, 1478-1487.
9. Baker, A. H., George, S. J., Zaltsman, A. B., Murphy, G. and Newby, A. C. (1999). Inhibition of invasion and induction of apoptotic cell death of cancer cell lines by overexpression of TIMP-3. Br. J. Cancer 79, 1347-1335.
10. Banyai, L. and Patthy, L. (1999). The NTR module: domains of netrins, secreted frizzled related proteins, and type I procollagen C-proteinase enhancer protein are homologous with tissue inhibitors of metalloproteases. Protein Sci. 8, 1636-1642.
11. Barmina, O., Walling, H., Fiacco, G., Freije, J., Lopez-Otin, C., Jeffrey, J. and Partridge, N. (1999). Collagenase-3 binds to a specific receptor and requires the low density lipoprotein receptor-related protein for internalization. J. Biol. Chem. 274, 30087-30093.
12. Bendeck, M. P., Zempo, N., Clowes, A. W., Galardy, R. E. and Reidy, M. A. (1994). Smooth muscle cell migration and matrix metalloproteinase expression after arterial injury in the rat. Circ. Res. 75, 539-545.
13. Bendeck, M. P., Irvin, C. and Reidy, M. A. (1996). Inhibition of matrix metalloproteinase activity inhibits smooth muscle cell migration but not neointimal thickening after arterial injury. Circ. Res. 78, 38-43.
14. Bergers, G., Javaherian, K., Lo, K., Folkman, J. and Hanahan, D. (1999). Effects of angiogenesis inhibitors on multistage carcinogenesis in mice. Science 284, 808-812.
15. Bertaux, B., Hornebeck, W., Eisen, A. Z. and Dubertret, L. (1991). Growth stimulation of human keratinocytes by tissue inhibitor of metalloproteinases. J. Invest. Dermatol. 97, 679-685.
16. Bian, J. H., Wang, Y. L., Smith, M. R., Kim, H., Jacobs, C., Jackman, J., Kong, H. F., Colburn, N. H. and Sun, Y. (1996). Suppression of in vivo tumor growth and induction of suspension cell death by tissue inhibitor of metalloproteinases (TIMP)-3. Carcinogenesis 17, 1805-1811.
17. Bigg, H., Morrison, C., Butler, G., Bogoyevitch, M., Wang, Z., Soloway, P. D. and Overall, C. (2001). Tissue inhibitor of metalloproteinases-4 inhibits but does not support the activation of gelatinase A via efficient inhibition of membrane type 1-matrix metalloproteinase. Cancer Res. 61, 3610-3618.
18. Bond, M., Murphy, G., Bennett, M. R., Amour, A., Knauper, V., Newby, A. C. and Baker, A. H. (2000). Localization of the death domain of tissue inhibitor of metalloproteinase-3 to the N terminus. Metalloproteinase inhibition is associated with proapoptotic phenotype. J. Biol. Chem. 275, 41358-41363.
19. Bond, M., Murphy, G., Bennett, M. R., Newby, A. C. and Baker, A. H. (2002). Tissue inhibitor of metalloproteinase-3 induces a Fas-associated death domain-dependent type II apoptotic pathway. J. Biol. Chem. 277, 13787-13795.
20. Bramhall, S. R., Hallissey, M. T., Whiting, J., Scholefield, J., Tierney, G., Stuart, R. C., Hawkins, R. E., McCulloch, P., Maughan, T., Brown, P. D., Baillet, M. and Fielding, J. W. (2002). Marimastat as maintenance therapy for patients with advanced gastric cancer: a randomised trial. Br. J. Cancer 86, 1864-1870.
21. Brand, K., Baker, A., Perez-Canto, A., Possling, A., Sacharjat, M., Geheeb, M. and Arnold, W. (2000). Treatment of colorectal liver metastases by adenoviral transfer of tissue inhibitor of metalloproteinases-2 into the liver tissue. Cancer Res. 60, 5723-5730.
22. Brew, K., Dinakarpandian, D. and Nagase, H. (2000). Tissue inhibitors of metalloproteinases: evolution, structure and function. Biochim. Biophys. Acta. 1477, 267-283.
23. Brown, P. D. (2000). Ongoing trials with matrix metalloproteinase inhibitors. Expert Opin. Investig. Drugs 9, 2167-2177.
24. Butler, G., Butler, M., Atkinson, S., Will, H., Tamura, T., van Westrum, S., Crabbe, T., Clements, J., d'Ortho, M. and Murphy, G. (1998). The TIMP2 membrane type 1 metalloproteinase "receptor" regulates the concentration and efficient activation of progelatinase A. A kinetic study. J. Biol. Chem. 273, 871-880.
25. Caterina, J. J., Yamada, S., Caterina, N. C., Longenecker, G., Holmbäck, K., Shi, J., Yermovsky, A. E., Engler, J. A. and Birkedal-Hansen, H. (2000). Inactivating mutation of the mouse tissue inhibitor of metalloproteinases-2(Timp-2) gene alters proMMP-2 activation. J. Biol. Chem. 275, 26416-26422.
26. Celiker, M., Wang, M., Atsidaftos, E., Liu, X., Liu, Y. E., Jiang, Y., Valderrama, E., Goldberg, I. D. and Shi, Y. (2001). Inhibition of Wilms' tumor growth by intramuscular administration of tissue inhibitor of metalloproteinases-4 plasmid DNA. Oncogene 20, 4337-4343.
27. Cheng, L., Mantile, G., Pauly, R., Nater, C., Felici, A., Monticone, R., Bilato, C., Gluzband, Y. A., Crow, M. T., Stetler-Stevenson, W. and Capogrossi, M. C. (1998). Adenovirus-mediated gene transfer of the human tissue inhibitor of metalloproteinase-2 blocks vascular smooth muscle cell invasiveness in vitro and modulates neointimal development in vivo. Circulation 98, 2195-2201.
28. Cherr, G., Motew, S., Travis, J., Fingerle, J., Fisher, L., Brandl, M., Williams, J. and Geary, R. (2002). Metalloproteinase Inhibition and the response to angioplasty and stenting in atherosclerotic primates. Arterioscler. Thromb. Vasc. Biol. 22, 161-166.
29. Chesler, L., Golde, D. W., Bersch, N. and Johnson, M. D. (1995). Metalloproteinase inhibition and erythroid potentiation are independent activities of tissue inhibitor of metalloproteinases-1. Blood 86, 4506-4515.
30. Corcoran, M. L. and Stetler-Stevenson, W. G. (1995). Tissue inhibitor of metalloproteinases-2 (TIMP-2) stimulates fibroblast proliferation via a cyclic adenosine 3′,5′-monophosphate (cAMP)-dependent mechanism. J. Biol. Chem. 270, 13453-13459.
31. Coussens, L. M., Shapiro, S. D., Soloway, P. D. and Werb, Z. (2001). Models for gain-of function and loss-of-function of MMPs. Methods Mol. Biol. 151, 149-179.
32. Coussens, L. M., Fingleton, B. and Matrisian, L. (2002). Matrix metalloproteinase inhibitors and cancer: trials and tribulations. Science 295, 2387-2392.
33. Creemers, E., Cleutjens, J., Smits, J. and Daemen, M. (2001). Matrix metalloproteinase inhibition after myocardial infarction: a new approach to prevent heart failure? Circ. Res. 89, 201-210.
34. de Smet, B. J., de Kleijn, D., Hanemaaijer, R., Verheijen, J. H., Robertus, L., van der Helm, Y. J., Borst, C. and Post, M. J. (2000). Metalloproteinase inhibition reduces constrictive arterial remodeling after balloon angioplasty. Circulation 101, 2962-2967.
35. Dollery, C. M., Humphries, S. E., McClelland, A., Latchman, D. S. and McEwan, J. R. (1999). Expression of tissue inhibitor of matrix metalloproteinases 1 by use of an adenoviral vector inhibits smooth muscle cell migration and reduces neointimal hyperplasia in the rat model of vascular balloon injury. Circulation 99, 3199-3205.
36. Edwards, D. R. (2000). The tissue inhibitors of metalloproteinases: biology and regulation. In Matrix Metalloproteinase Inhibitors in Cancer Therapy (ed. N. J. Clendennin and K. Appelt), pp. 67-84. Totawa, NJ: Humana Press.
37. Edwards, D. R., Beaudry, P. P., Laing, T. D., Kowal, V., Leco, K. J., Leco, P. A. and Lim, M. S. (1996). The roles of tissue inhibitors of metalloproteinases in tissue remodelling and cell growth. Int. J. Obes. Relat. Metab. Disord. 20, Suppl. 3, S9-S15.
38. Egeblad, M. and Werb, Z. (2002). New functions for the matrix metalloproteinases in cancer progression. Nat. Rev. Cancer 2, 161-174.
39. Evans, J. D., Stark, A., Johnson, C. D., Daniel, F., Carmichael, J., Buckels, J., Imrie, C. W., Brown, P. and Neoptolemos, J. P. (2001). A phase II trial of marimastat in advanced pancreatic cancer. Br. J. Cancer 85, 1865-1870.
40. Fata, J., Leco, K., Voura, E., Yu, H., Waterhouse, P., Murphy, G., Moorehead, R. and Khokha, R. (2001). Accelerated apoptosis in the timp-3-deficient mammary gland. J. Clin. Invest. 108, 831-841.
41. Forough, R., Koyama, N., Hasenstab, D., Lea, H., Clowes, M., Nikkari, S. T. and Clowes, A. W. (1996). Overexpression of tissue inhibitor of matrix metalloproteinase-1 inhibits vascualr smooth muscle cell functions in vitro and in vivo. Circ. Res. 79, 812-820.
42. Gasson, J. C., Golde, D. W., Kaufman, S. E., Westbrook, C. A., Hewick, R. M., Kaufman, R. J., Wong, G. G., Temple, P. A., Leary, A. C., Brown, E. L. et al. (1985). Molecular characterization and expression of the gene encoding human erythroid-potentiating activity. Nature 315, 768-771.
43. George, S. J. (1998). Tissue inhibitors of metalloproteinases and metalloproteinases in atherosclerosis. Curr. Opin. Lipidol. 9, 413-423.
44. George, S. J., Zaltsman, A. B. and Newby, A. C. (1997). Surgical preparative injury and neointima formation increase MMP-9 expression and MMP-2 activation in human saphenous vein. Cardiovasc. Res. 33, 447-459.
45. George, S. J., Baker, A. H., Angelini, G. D. and Newby, A. C. (1998a). Gene transfer of tissue inhibitor of metalloproteinase-2 inhibits metalloproteinase activity and neointima formation in human saphenous veins. Gene Therapy 5, 1552-1560.
46. George, S. J., Johnson, J. L., Angelini, G. D., Newby, A. C. and Baker, A. H. (1998b). Adenovirus-mediated gene transfer of the human TIMP-1 gene inhibits SMC migration and neointima formation in human saphenous vein. Hum. Gene Ther. 9, 867-877.
47. George, S. J., Lloyd, C. T., Angelini, G. D., Newby, A. C. and Baker, A. H. (2000). Inhibition of late vein graft neointima formation in human and porcine models by adenovirus-mediated overexpression of tissue inhibitor of metalloproteinase-3. Circulation 101, 296-304.
48. Godenschwege, T., Pohar, N., Buchner, S. and Buchner, E. (2000). Inflated wings, tissue autolysis and early death in tissue inhibitor of metalloproteinases mutants of Drosophila. Eur. J. Cell Biol. 79, 495-501.
49. Gomis-Ruth, F., Maskos, K., Betz, M., Bergner, A., Huber, R., Suzuki, K., Yoshida, N., Nagase, H., Brew, K., Bourenkov, G. et al. (1997). Mechanism of inhibition of the human matrix metalloproteinase stromelysin-1 by TIMP-1. Nature 389, 77-81.
50. Grignon, D. J., Sakr, W., Toth, M., Ravery, V., Angulo, J., Shamsa, F., Pontes, J. E., Crissman, J. C. and Fridman, R. (1996). High levels of tissue inhibitor of metalloproteinase-2 (TIMP-2) expression are associated with poor outcome in invasive bladder cancer. Cancer Res. 56, 1654-1659.
51. Guedez, L., Stetler-Stevenson, W. G., Wolff, L., Wang, J., Fukushima, P., Mansoor, A. and Stetler-Stevenson, M. (1998). In vitro suppression of programmed cell death of B cells by tissue inhibitor of metalloproteinases-1. J. Clin. Invest. 102, 2002-2010.
52. Hahn-Dantona, E., Ruiz, J., Bornstein, P. and Strickland, D. (2001). The low density lipoprotein receptor-related protein modulates levels of matrix metalloproteinase 9 (MMP-9) by mediating its cellular catabolism. J. Biol. Chem 276, 15498-15503.
53. Hayakawa, T., Yamashita, K., Tanzawa, K., Uchijima, E. and Iwata, K. (1992). Growth promoting activity of tissue inhibitor of metalloproteinases-1 (TIMP-1) for a wide range of cells. FEBS Lett. 298, 29-32.
54. Hayakawa, T., Yamashita, K., Ohuchi, E. and Shinagawa, A. (1994). Cell growth-promoting activity of tissue inhibitor of metalloproteinases-2 (TIMP-2). J. Cell. Sci. 107, 2373-2379.
55. Herman, M., Sakhova, G., Kisiel, W., Foster, D., Kehry, M., Libby, P. and Schonbeck, U. (2001). Tissue factor pathway inhibitor-2 is a novel inhibitor of matrix metalloproteinases with implications for atherosclerosis. J. Clin. Invest. 107, 1117-1126.
56. Itoh, T., Tanioka, M., Yoshida, H., Yoshioka, T., Nishimoto, H. and Itohara, S. (1998). Reduced angiogenesis and tumor progression in gelatinase A-deficient mice. Cancer Res. 5, 1048-1051.
57. Jiang, Y., Wang, M., Celiker, M., Liu, Y., Sang, Q., Goldberg, I. and Shi, Y. (2001). Stimulation of mammary tumorigenesis by systemic inhibitor of matrix metalloproteinase 4 gene delivery. Cancer Res. 61, 2365-2370.
58. Kashiwagi, M., Tortorella, M., Nagase, H. and Brew, K. (2001). TIMP-3 is a potent inhibitor of aggrecanase 1 (ADAM-TS4) and aggrecanase 2 (ADAM-TS5). J. Biol. Chem. 276, 12501-12504.
59. Kim, H., Oda, T., Lopez-Guisa, J., Wing, D., Edwards, D. R., Soloway, P. D. and Eddy, A. A. (2001). TIMP-1 deficiency does not attenuate interstitial fibrosis in obstructive nephropathy. J. Am. Soc. Nephrol. 12, 736-748.
60. Kossakowska, A. E., Urbanski, S. J. and Edwards, D. R. (1991). Tissue inhibitor of metalloproteinases-1 (TIMP-1) RNA is expressed at elevated levels in malignant Non-Hodgkin's lymphomas. Blood 77, 2475-2481.
61. Leco, K. J., Khokha, R., Pavloff, N., Hawkes, S. F. and Edwards, D. R. (1994). Tissue inhibitor of metalloproteinases-3 (Timp-3) is an extracellular matrix-associated protein with a distinctive pattern of expression in mouse cells and tissues. J. Biol. Chem. 269, 9352-9360.
62. Leco, K. J., Waterhouse, P., Sanchez, O. H., Gowing, K. L. M., Poole, A. R., Wakeham, A., Mak, T. W. and Khokha, R. (2001). Spontaneous air space enlargement in the lungs of mice lacking tissue inhibitor of metalloproteinases-3 (TIMP-3). J. Clin. Invest. 108, 817-829.
63. Li, H., Nishio, K., Yamashita, K., Hayakawa, T. and Hoshino, T. (1995). Cell cycle-dependent localization of tissue inhibitor of metalloproteinases-1 immunoreactivity in cultured human gingival fibroblasts. Nagoya J. Med. Sci. 58, 133-142.
64. Martignetti, J. A., Aqeel, A. A., Sewairi, W. A., Boumah, C. E., Kambouris, M., Mayouf, S. A., Sheth, K. V., Eid, W. A., Dowling, O., Harris, J. et al. (2001). Mutation of the matrix metalloproteinase 2 gene (MMP2) causes a multicentric osteolysis and arthritis syndrome. Nat. Genet. 28, 261-265.
65. Moestrup, S., Holtet, T., Etzerodt, M., Thogersen, H., Nykjaer, A., Andreasen, P., Rasmussen, H., Sottrup-Jensen, L. and Gliemann, J. (1993). Alpha 2-macroglobulin-proteinase complexes, plasminogen activator inhibitor type-1-plasminogen activator complexes, and receptor-associated protein bind to a region of the alpha 2-macroglobulin receptor containing a cluster of eight complement-type repeats. J. Biol. Chem. 268, 13691-13696.
66. Nagase, H. (1997). Activation mechanisms of matrix metalloproteinases. J. Biol. Chem. 378, 151-160.
67. Nemeth, J. A., Rafe, A., Steiner, M. and Goolsby, C. L. (1996). TIMP-2 growth-stimulatory activity, a concentration- and cell type-specific response in the presence of insulin. Exp. Cell Res. 224, 110-115.
68. Nothnick, W. B. (2001). Reduction in reproductive lifespan of tissue inhibitor of metalloproteinase 1 (TIMP-1)-deficient female mice. Reproduction 122, 923-927.
69. Oelmann, E., Herbst, H., Zühlsdorf, M., Albrecht, O., Nolte, A., Schmitmann, C., Manzke, O., Diehl, V., Stein, H. and Berdel, W. E. (2002) Tissue inhibitor of metalloproteinases 1 is an autocrine and paracrine survival factor, with additional immune-regulatory functions, expressed by Hodgkin/Reed-Sternberg cells. Blood 99, 258-267.
70. Oh, J., Takahashi, R., Kondo, S., Mizoguchi, A., Adachi, E., Sasahara, R., Nishimura, S., Imamura, Y., Kitayama, H., Alexander, D. et al. (2001). The membrane-anchored MMP inhibitor RECK is a key regulator of extracellular matrix integrity and angiogenesis. Cell 107, 789-800.
71. Pyo, R., Lee, J. K., Shipley, J. M., Curci, J. A., Mao, D., Ziporin, S. J., Ennis, T. L., Shapiro, S. D., Senior, R. M. and Thompson, R. W. (2000). Targeted gene disruption of matrix metalloproteinase-9 (gelatinase B) suppresses development of experimental abdominal aortic aneurysms. J. Clin. Invest. 105, 1641-1649.
72. Ritter, L. M., Garfield, S. H. and Thorgeirsson, U. P. (1999). Tissue inhibitor of metalloproteinases-1 (TIMP-1) binds to the cell surface and translocates to the nucleus of human MCF-7 breast carcinoma cells. Biochem. Biophys. Res. Commun. 257, 494-499.
73. Rouis, M., Adamy, C., Duverger, N., Lesnik, P., Horellou, R, Moreau, M., Emmanuel, F., Caillaud, J. M., Lapland, P. M., Dachet, C. et al. (1999). Adenovirus-mediated overexpression of tissue inhibitor of metalloproteinase-1 reduces atherosclerotic lesions in apolipoprotein E-deficient mice. Circulation 100, 533-540.
74. Silence, J., Collen, D. and Lijnen, H. R. (2002). Reduced atherosclerotic plaque but enhanced aneurysm formation in mice with inactivation of the tissue inhibitor of metalloproteinase-1 (TIMP-1) gene. Circ. Res. 90, 897-903.
75. Smith, M. R., Kong, H. F., Durum, S. K., Colburn, N. H. and Sun, Y. (1997). TIMP-3 induces cell death by stabilizing TNF-alpha receptors on the surface of human colon carcinoma cells. Cytokine 9, 770-780.
76. Sobue, T., Hakeda, Y., Kobayashi, Y., Hayakawa, H., Yamashita, K., Aoki, T., Kumegawa, M., Noguchi, T. and Hayakawa, T. (2001). Tissue inhibitor of metalloproteinases 1 and 2 directly stimulate the bone-resorbing activity of isolated mature osteoclasts. J. Bone Miner. Res. 16, 2205-2214.
77. Southgate, K. M., Fisher, M., Banning, A. P., Thurston, V. J., Baker, A. H., Fabunmi, R. P., Groves, P. H., Davies, M. and Newby, A. C. (1996). Upregulation of basement-membrane-degrading metalloproteinase secretion following balloon injury of pig carotid arteries. Circ. Res. 79, 1177-1187.
78. Southgate, K., Mehta, D., Izzat, M., Newby, A. and Angelini, G. (1999). Increased secretion of basement membrane degrading metalloproteinases in pig saphenous vein into carotid artery interposition grafts. Arterioscler. Thromb. Vasc. Biol. 19, 1640-1649.
79. Stetler-Stevenson, W. G., Bersch, N. and Golde, D. W. (1992). Tissue inhibitor of metalloproteinase-2 (TIMP-2) has erythroid-potentiating activity. FEBS Lett. 296, 231-234.
80. Stetler-Stevenson, M., Mansoor, A., Lim, M. S., Fukushima, P., Kerhl, J., Marti, G., Ptaszynski, K., Wang, J. and Stetler-Stevenson, W. G. (1997). Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases (TIMPs). in reactive and neoplastic lymph nodes. Blood 89, 1708-1715.
81. Takahashi, C., Sheng, Z., Horan, T., Kitayama, H., Maki, M., Hitomi, K., Kitaura, Y., Takai, S., Sasahara, R., Horimoto, A. et al. (1998). Regulation of matrix metalloproteinase-9 and inhibition of tumor invasion by the membrane-anchored glycoprotein RECK. Proc. Natl. Acad. Sci. USA 95, 13221-13226.
82. Toth, M., Bernardo, M. M., Gervasi, D. C., Soloway, P. D., Wang, Z., Bigg, H. E., Overall, C. M., DeClerck, Y. A., Tschesche, H., Cher, M. L. et al. (2000). Tissue inhibitor of metalloproteinase (TIMP)-2 acts synergistically with synthetic matrix metalloproteinase (MMP) inhibitors but not with TIMP-4 to enhance the (membrane type 1)-MMP-dependent activation of pro-MMP-2. J. Biol. Chem.. 275, 41415-41423.
83. Vaillant, B., Chiaramonte, M., Cheever, A., Soloway, P. and Wynn, T. (2001). Regulation of hepatic fibrosis and extracellular matrix genes by the Th response: new insight into the role of tissue inhibitors of matrix metalloproteinases. J. Immunol. 167, 7017-7026.
84. Valente, P., Fassina, G., Melchiori, A., Masiello, L., Cilli, M., Vacca, A., Onisto, M., Santi, L., Stetler-Stevenson, W. G. and Albini, A. (1998). TIMP-2 over-expression reduces invasion and angiogenesis and protects B16F10 melanoma cells from apoptosis. Int. J. Cancer 75, 246-253.
85. Wang, Z., Juttermann, R. and Soloway, P. D. (2000). TIMP-2 is required for efficient activation of proMMP-2 in vivo. J. Biol. Chem. 275, 26411-26415.
86. Werb, Z. (1997). ECM and cell surface proteolysis, regulating cellular ecology. Cell 91, 439-442.
87. Wingfield, P. T., Sax, J. K., Stahl, S. J., Kaufman, J., Palmer, L, Chung, V., Corcoran, M. L., Kleiner, D. E. and Stetler-Stevenson, W. G. (1999). Biophysical and functional characterization of full length recombinant human tissue inhibitor of metalloproteinases-2 (TIMP-2) produced in Escherischia coli. J. Biol. Chem. 274, 21362-21368.
88. Yang, T.-T. and Hawkes, S. P. (1992). Role of the 21-kDa protein TIMP-3 in oncogenic transformation of cultured chicken embryo fibroblasts. Proc. Natl. Acad. Sci. USA 89, 10676-10680.
89. Yu, W. H., Yu, S., Meng, Q., Brew, K. and Woessner, J. F., Jr (2000). TIMP-3 binds to sulphated glycosaminoglycans of the extracellular matrix. J. Biol. Chem. 275, 31226-31232.
90. Zempo, N., Kenagy, R. D., Au, Y. P., Bendeck, M., Clowes, M. M., Reidy, M. A. and Clowes, A. W. (1994). Matrix metalloproteinases of vascular wall cells are increased in balloon-injured rat carotid artery. J. Vasc. Surg. 20, 209-217.